Moderna Analyst Downgrades COVID-19 Vaccine Developer, Sees 'Changing Competitive Environment'Benzinga • 09/08/20
SVB analysts downgrade Moderna's stock, citing 'competitive pressure' from other COVID vaccine developersMarket Watch • 09/08/20
Nine biopharma CEOs pledge to make safety the main focus in coronavirus vaccine developmentCNBC • 09/08/20
Moderna, Pfizer, Johnson & Johnson, And Others To Make Pledge in Response to Coronavirus Vaccine Political PressureThe Motley Fool • 09/05/20
Moderna Pulling Back on Coronavirus Vaccine Trial Enrollment to Get More Minority Patients InvolvedThe Motley Fool • 09/04/20
Moderna's stock falls 4% as CEO says enrollment in vaccine trial has been slowed to ensure diversityMarket Watch • 09/04/20
Moderna slows coronavirus vaccine trial enrollment to ensure minority representation, CEO saysCNBC • 09/04/20
3 Drugmakers Most Likely to Launch Coronavirus Vaccines in the U.S. by the End of 2020The Motley Fool • 09/04/20
As CDC Issues Notice, Stock Market Bets Which Company Gets First COVID-19 Vaccine FDA Approval24/7 Wall Street • 09/02/20
How You Might Own a Stake in Moderna's Coronavirus Vaccine Without Even Knowing ItThe Motley Fool • 09/02/20
FDA Willing to Authorize Coronavirus Vaccine Before Phase 3 Trials Are Complete, Agency Head SaysThe Motley Fool • 08/31/20